Alpha-synuclein pathology and axonal degeneration of the peripheral motor nerves innervating pharyngeal muscles in parkinson disease

Journal of Neuropathology and Experimental Neurology

Volumn 72, Issue 2, 2013, Pages 119-129

  Mu, Liancai ^a   Sobotka, Stanislaw ^a,b   Chen, Jingming ^a   Su, Hungxi ^a   Sanders, Ira ^a   Adler, Charles H ^c   Shill, Holly A ^d   Caviness, John N ^c   Samanta, Johan E ^d,e   Beach, Thomas G ^d  

^a HACKENSACK UNIVERSITY MEDICAL CENTER   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c MAYO CLINIC   (United States)

^d SUN HEALTH RESEARCH INSTITUTE   (United States)

^e BANNER GOOD SAMARITAN MEDICAL CENTER   (United States)

Author keywords

Alpha synuclein aggregates; Dysphagia; Intramuscular nerve twigs; Lewy bodies; Lewy neurites; Motor nerve; Parkinson disease; Pharyngeal constrictor muscles; Pharyngeal plexus; Upper esophageal sphincter; Vagus nerve.

Indexed keywords

ALPHA SYNUCLEIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DENSITY; DYSPHAGIA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MOTOR NERVE; MUSCLE INNERVATION; NERVE ENDING; NERVE FIBER DEGENERATION; NEUROMUSCULAR SYNAPSE; NEUROPATHOLOGY; PARKINSON DISEASE; PERIPHERAL NERVE; PHARYNX; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REPEAT PROCEDURE; SYMPATHETIC TRUNK; VAGUS NERVE;

ACETYLCHOLINESTERASE; AGED; AGED, 80 AND OVER; ALPHA-SYNUCLEIN; AXONS; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; NERVE DEGENERATION; NEUROLOGIC EXAMINATION; NEUROMUSCULAR JUNCTION; PARKINSON DISEASE; PHARYNGEAL MUSCLES; SILVER STAINING; VAGUS NERVE;

EID: 84872863398     PISSN: 00223069     EISSN: 15546578     Source Type: Journal    
DOI: 10.1097/NEN.0b013e3182801cde     Document Type: Article

References (80)

1. Jellinger KA. Pathology of Parkinson's disease. Changes other than the nigrostriatal pathway. Mol Chem Neuropathol 1991;14:153-97
2. Johnston BT, Li Q, Castell JA, et al. Swallowing and esophageal function in Parkinson's disease. Am J Gastroenterol 1995;90:1741-46
3. Leopold NA, Kagel MC. Prepharyngeal dysphagia in Parkinson's disease. Dysphagia 1996;11:14-22
4. Coates C, Bakheit AM. Dysphagia in Parkinson's disease. Eur Neurol 1997;38:49-52
5. Fuh JL, Lee RC, Wang SJ, et al. Swallowing difficulty in Parkinson's disease. Clin Neurol Neurosurg 1997;99:106-12
6. Ertekin C, Tarlaci S, Aydogdu I, et al. Electrophysiological evaluation of pharyngeal phase of swallowing in patients with Parkinson's disease. Mov Disord 2002;17:942-49
7. Sapir S, Ramig L, Fox C. Speech and swallowing disorders in Parkinson disease. Curr Opin Otolaryngol Head Neck Surg 2008;16:205-10
8. Sapir S, Ramig L, Fox C. Voice, speech and swallowing disorders. In: Factor S, Weiner W, eds. Parkinson Disease: Diagnosis and Clinical Management. New York City, NY: Demos Medical Publishing, 2008:77-97
9. Logemann JA, Fisher HB, Boshes B, et al. Frequency and cooccurrence of vocal tract dysfunctions in the speech of a large sample of Parkinson patients. J Speech Hear Disord 1978;42:47-57
10. Hartelius L, Svensson P. Speech and swallowing symptoms associated with Parkinson's disease and multiple sclerosis: A survey. Folia Phoniatr Logop 1994;46:9-17
11. Spillantini MG, Schmidt ML, Lee VM, et al. >-Synuclein in Lewy bodies. Nature 1997;388:839-40
12. Marrachelli VG, Miranda FJ, Alabadi JA, et al. Perivascular nerve fiber alpha-synuclein regulates contractility of mouse aorta: A link to autonomic dysfunction in Parkinson's disease. Neurochem Int 2010;56:991-98
13. Papachroni K, Ninkina N, Wanless J, et al. Peripheral sensory neurons survive in the absence of alpha-and gamma-synuclein. J Mol Neurosci 2005;25:157-64
14. Clayton DF, George JM. The synucleins: A family of proteins involved in synaptic function, plasticity, neurodegeneration and disease. Trends Neurosci 1998;21:249-54
15. Bennett MC. The role of alpha-synuclein in neurodegenerative diseases. Pharmacol Ther 2005;105:311-31
16. Amino T, Orimo S, Itoh Y, et al. Profound cardiac sympathetic denervation occurs in Parkinson disease. Brain Pathol 2005;15:29-34
17. Orimo S, Amino T, Itoh Y, et al. Cardiac sympathetic denervation precedes neuronal loss in the sympathetic ganglia in Lewy body disease. Acta Neuropathol 2005;109:583-88
18. Orimo S, Takahashi A, Uchihara T, et al. Degeneration of cardiac sympathetic nerve begins in the early disease process of Parkinson's disease. Brain Pathol 2007;17:24-30
19. Orimo S, Uchihara T, Nakamura A, et al. Axonal >-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease. Brain 2008;131:642-50
20. Fujishiro H, Frigerio R, Burnett M, et al. Cardiac sympathetic denervation correlates with clinical and pathologic stages of Parkinson's disease. Mov Disord 2008;23:1085-92
21. Wakabayashi K, Takahashi H, Ohama E, et al. Parkinson's disease: An immunohistochemical study of Lewy body-containing neurons in the enteric nervous system. Acta Neuropathol (Berl) 1990;79:581-83
22. Braak H, de Vos RAI, Bohl J, et al. Gastric >-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology. Neurosci Lett 2006;396: 67-72
23. Bloch A, Probst A, Bissig H, et al. >-Synuclein pathology of the spinal and peripheral autonomic nervous system in neurologically unimpaired elderly subjects. Neuropathol Appl Neurobiol 2006;32:284-95
24. Michell AW, Luheshi LM, Barker RA. Skin and platelet >-synuclein as peripheral biomarkers of Parkinson's disease. Neurosci Lett 2005;381: 294-98
25. Dabby R, Djaldetti R, Shahmurov M, et al. Skin biopsy for assessment of autonomic denervation in Parkinson's disease. J Neural Transm 2006; 113:1169-76
26. Ikemura M, Saito Y, Sengoku R, et al. Lewy body pathology involves cutaneous nerves. J Neuropathol Exp Neurol 2008;67:945-53
27. Miki Y, Tomiyama M, Ueno T, et al. Clinical availability of skin biopsy in the diagnosis of Parkinson's disease. Neurosci Lett 2010;469:357-59
28. Shishido T, Ikemura M, Obi T, et al. >-Synuclein accumulation in skin nerve fibers revealed by skin biopsy in pure autonomic failure. Neurology 2010;74:608-10
29. Mu L, Sobotka S, Chen J, et al. Altered pharyngeal muscles in Parkinson's disease. J Neuropathol Exp Neurol 2012;71:520-30
30. Stelzig Y, Hochhaus W, Gall V, et al. Kehlkopfbefunde bei Patienten mit Morbus Parkinson. Laryngeal findings of patients with Parkinson's disease [with English abstract]. Laryngo-Rhino-Otol 1999;78:544-51
31. Meyer TK. The larynx for neurologists. The Neurologist 2009;15:313-18
32. Mu L, Sanders I. The innervation of the human upper esophageal sphincter. Dysphagia 1996;11:234-38
33. Mu L, Sanders I. Neuromuscular organization of the human upper esophageal sphincter. Ann Otol Rhinol Laryngol 1998;107:370-77
34. Mu L, Sanders I. Neuromuscular compartments and fiber-type regionalization in the human inferior pharyngeal constrictor muscle. Anat Rec 2001;264:367-77
35. Mu L, Sanders I. Neuromuscular specializations within human pharyngeal constrictor muscles. Ann Otol Rhinol Laryngol 2007;116:604-17
36. Mu L, Sanders I. Newly revealed cricothyropharyngeus muscle in the human laryngopharynx. Anat Rec 2008;291:927-38
37. Sanders I, Wu BL, Mu L, et al. The innervation of the human larynx. Arch Otolaryngol Head Neck Surg 1993;119:934-39
38. Sanders I, Mu L, Wu BL, et al. The intramuscular nerve supply of the human lateral cricoarytenoid muscle. Acta Otolaryngol (Stock) 1993;113: 679-82
39. Sanders I, Wu BL, Mu L, et al. The innervation of the human posterior cricoarytenoid muscle. Laryngoscope 1994;104:880-84
40. Mu L, Sanders I, Wu BL, et al. The intramuscular innervation of the human interarytenoid muscle. Laryngoscope 1994;104:33-39
41. Mu L, Sanders I. The human cricothyroid muscle: Three muscle bellies and their innervation patterns. J Voice 2009;23:21-28
42. Del Tredici K, Braak H. A not entirely benign procedure: Progression of Parkinson's disease. Acta Neuropathol 2008;115:379-84
43. Del Tredici K, Hawkes CH, Ghebremedhin E, et al. Lewy pathology in the submandibular gland of individuals with incidental Lewy body disease and sporadic Parkinson's disease. Acta Neuropathol 2010;119: 703-13
44. Beach TG, Adler CH, Sue LI, et al. Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders. Acta Neuropathol 2010;119:689-702
45. Berthoud HR, Neuhuber WL. Functional and chemical anatomy of the afferent vagal system. Auton Neurosci 2000;85:1-17
46. Beach TG, Sue LI, Walker DG, et al. The Sun Health Research Institute Brain Donation Program: Description and experience, 1987-2007. Cell Tissue Bank 2008;9:229-45
47. Hoehn MM, Yahr MD. Parkinsonism: Onset, progression and mortality. Neurology 1967;17:427-42
48. Fahn S, Elton R, , Committee DU. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Goldstein M, Calne DB, eds. Recent Developments in Parkinson's Disease. New York, NY: MacMillan, 1987: 153-63
49. Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol 1999;56:33-39
50. Eriksson PO, Eriksson A, Ringqvist M, et al. The reliability of histochemical fiber typing of human necropsy muscles. Histochemistry 1980; 65:193-205
51. Eriksson PO, Thornell LE. Histochemical and morphological musclefiber characteristics of the human masseter, the medial pterygoid and the temporal muscles. Arch Oral Biol 1983;28:781-95
52. Beach TG, White CL, Hamilton RL, et al. Evaluation of alpha-synuclein immunohistochemical methods used by invited experts. Acta Neuropathol 2008;116:277-88
53. Fujiwara H, Hasegawa M, Dohmae N, et al. >-Synuclein is phosphorylated in synucleinopathy lesions. Nat Cell Biol 2002;4:160-64
54. Beach TG, Adler CH, Lue L, et al. Unified staging system for Lewy body disorders: Correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction. Acta Neuropathol 2009;117:613-34
55. Tam SL, Archibald V, Tyreman N, et al. Increased neuromuscular activity reduces sprouting in partially denervated muscles. J Neurosci 2001;21: 654-67
56. The National Institute on Aging and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. Neurobiol Aging 1997;18:S1-S2
57. Litvan I, Bhatia KP, Burn DJ, et al. Movement Disorders Society Scientific Issues Committee. Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov Disord 2003;18:467-86
58. Berardelli A, Rothwell JC, Thompson PD, et al. Pathophysiology of bradykinesia in Parkinson's disease. Brain 2001;124:2131-46
59. Caviness JN, Smith BE, Stevens JC, et al. Motor unit changes in sporadic idiopathic Parkinson's disease. Mov Disord 2000;15:238-43
60. Toth C, Breithaupt K, Ge S, et al. Levodopa, methylmalonic acid, and neuropathy in idiopathic Parkinson disease. Ann Neurol 2010;67:28-36
61. Brait K, Fahn S, Schwarz GA. Sporadic and familial parkinsonism and motor neuron disease. Neurology 1973;23:990-1002
62. Sica RE, Herskovits E, Aguilera N, et al. An electrophysiological investigation of skeletal muscle in Parkinson's disease. J.Neurol Sci 1973;18: 411-20
63. Sica RE, Sanz OP. An electrophysiological study of the functional changes in the spinal motoneurones in Parkinson's disease. Electromyogr Clin Neurophysiol 1976;16:409-17
64. Taly AB, Muthane UB. Involvement of peripheral nervous system in juvenile Parkinson's disease. Acta Neurol Scand 1992;85:272-25
65. Caviness JN, Smith BE, Clarke SJ, et al. Motor unit number estimates in idiopathic Parkinson's disease. Parkinsonism Relat Disord 2002;8:161-64
66. Abbruzzese G, Pigullo S, Schenone A, et al. Does parkin play a role in the peripheral nervous system? A family report. Mov Disord 2004;19:978-81
67. Hunker CJ, Abbs JH, Barlow SM. The relationship between parkinsonian rigidity and hypokinesia in the orofacial system: A quantitative analysis. Neurology 1982;32:749-54
68. Ali GN, Wallace KL, Schwartz R, et al. Mechanisms of oral-pharyngeal dysphagia in patients with Parkinson's disease. Gastroenterology 1996; 110:383-92
69. Hunter PC, Crameri J,Austin S, et al. Response of parkinsonian swallowing dysfunction to dopaminergic stimulation. J Neurol Neurosurg Psychiatry 1997;63:579-83
70. Leopold NA, Kagel MC. Pharyngo-esophageal dysphagia in Parkinson's disease. Dysphagia 1997;12:11-18
71. Sapir S, Ramig L, Fox C. The Lee Silverman Voice Treatment for voice, speech and other orofacial disorders in patients with Parkinson's disease. Future Neurol 2006;1:563-70
72. Ramig L, Fox C, Sapir S. Speech treatment for Parkinson disease. Exp Rev Neurother 2008;8:299-311
73. Nilsson H, Ekberg O, Olsson R, et al. Quantitative assessment of oral and pharyngeal function in Parkinson's disease. Dysphagia 1996;11: 144-50
74. Jankovic J. Parkinson's disease: Clinical features and diagnosis. J Neurol Neurosurg Psychiatry 2008;79:368-76
75. Bushmann M, Dobmeyer SM, Leeker L, et al. Swallowing abnormalities and their response to treatment in Parkinson's disease. Neurology 1989; 39:1309-14
76. Kurihara K, Kita K, Hirayama K, et al. Dysphagia in Parkinson's disease. Clin Neruol 1993;33:150-54
77. Standring S, Ellis H, Healy JC, et al. Gray's Anatomy. The Anatomical Basis of Clinical Practice. 39th ed. New York, NY: Churchill Livingstone, 2005
78. Braak H, Rub U, Gai WP, et al. Idiopathic Parkinson's disease: Possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J Neural Transm 2003;110:517-36
79. Del Tredici K, Rub U, De Vos RAI, et al. Where does Parkinson disease pathology begin in the brain? J Neuropathol Exp Neurol 2002;61:413-26
80. Hawkes CH, Del Tredici K, Braak H. Parkinson's disease: A dual-hit hypothesis. Neuropathol Appl Neurobiol 2007;33:599-614